secwatch / observer
8-K filed June 17, 2026, 4:49 PM ET ticker CNMD CIK 0000816956
leadership confidence high sentiment neutral materiality 0.55

CONMED appoints John E. Gallagher as CFO effective July 15, 2026

CONMED Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John E. Gallagher

Executive Vice President, Chief Financial Officer
CNMD · CONMED Corp
Effective
2026-07-15
Filed
June 17, 2026, 4:49 PM ET
On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John E. Gallagher was appointed as Executive Vice President, Chief Financial Officer at CONMED Corp.

Action
appointed
Role
Executive Vice President, Chief Financial Officer
Exact text from the filing
On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”).
View on SEC.gov

CONMED Corp filing history →

Source: SEC EDGAR
accession 0002077096-26-000203
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.